SCHEMBL5008718

SCHEMBL5008718

N#Cc1ncccc1-c1cc(CCNC(=O)O)cn1S(=O)(=O)c1cccs1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
LMNA P02545 3/20 0.38
MAPT P10636 3/20 0.38
PKM P14618 3/20 0.38
MAPK1 P28482 2/20 0.38
RAB9A P51151 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
PAX8 Q06710 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GAA P10253 1/20 0.37
HTT P42858 2/20 0.36
KMT2A Q03164 1/20 0.35
IDE P14735 1/20 0.35
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.33
SLC6A9 P48067 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2408483 0.87 IDE (0.35) ALDH1A1GAAKMT2AIDE
SCHEMBL5002744 0.85 IDE (0.36) IDE
SCHEMBL1581216 0.84 PKM (0.42) ALDH1A1LMNAMAPTPKMMAPK1
SCHEMBL2410817 0.83 SLC40A1 (0.34) ALDH1A1RAB9A
SCHEMBL5008412 0.83 RAB9A (0.34) ALDH1A1MAPK1RAB9AKMT2ASMN1; SMN2
SCHEMBL4998963 0.83 PTGDR2 (0.34) ALDH1A1LMNAMAPTRAB9AKMT2A
Hydrochloric Acid SCHEMBL2414673 0.83 PKM (0.41) ALDH1A1LMNAMAPTPKMMAPK1
SCHEMBL5005952 0.83 NPC1 (0.32) ALDH1A1LMNAMAPTPKMRAB9A
SCHEMBL5002575 0.83 PTGDR2 (0.39) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL5008713 0.83 ALDH1A1 (0.38) ALDH1A1LMNAMAPTPKMMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114917-B1 PYRROLE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2016-08-10 EP disclosed
US-8933105-B2 Pyrrole compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-01-13 US disclosed
US-20080262042-A1 1-[5-(2-Fluoropyridin-3-yl)-1-(phenylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine or a salt thereof; acid secretion inhibitor; potassium-competitive acid blocker TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262042-A1 1-[5-(2-Fluoropyridin-3-yl)-1-(phenylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine or a salt thereof; acid secretion inhibitor; potassium-competitive acid blocker REN, HRH2, ATP4A ALDH1A1 1650/4885LMNA 3758/4885MAPT 4532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.